The global magnetoencephalography market size is expected to reach USD 432.56 million by 2030, expanding at a CAGR of 5.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The growing frequency of new product launches and the rise in the incidence of neurological disorders such as epilepsy, and stroke are key drivers to market growth. In addition, the growing geriatric population is also expected to drive market growth since they are more prone to neurodegenerative diseases. According to the World Health Organization, neurological disorders are a leading cause of death, accounting for 12% of all deaths worldwide.
MEG technologies detect the weak magnetic fields created in the brain and use them to quantify brain functionality and map brain activity. In a clinical setting, MEG provides a number of inherent applications. Scans can be performed in a safe and silent atmosphere due to the passive nature of the recordings, which even allows a patient's companion to be present within the shielded area.
Technological developments are likely to contribute to market expansion, such as the introduction of whole-head systems and developments in computer technology, MEG has evolved significantly in the last two decades. Whenever a precise and high degree of localization is required, MEG is now the imaging modality of choice. Furthermore, magnetoencephalography (MEG), is an invaluable tool that is used by researchers to study the connections and dynamics of large-scale brain activity.
The market's prominent competitors are acquiring medium and small-sized businesses in order to expand their product portfolio and enhance their manufacturing capacity. For instance, the University of Nottingham has partnered with Magnetic Shields Limited (MSL) of Kent to develop Cerca Magnetics Limited, a new spin-out company that will deliver the world's most advanced functional wearable brain scanner to market. It is designed to let people move around freely while being scanned.
Request a free sample copy or view report summary: Magnetoencephalography Market Report
By application, the clinical segment dominated the market in 2023 and is further expected to grow at the fastest CAGR of about 6.0% over the forecast period.
The clinical segment is further sub-segmented into dementia, autism, schizophrenia, multiple sclerosis, stroke, epilepsy, and others, in which the epilepsy sub-segment held the largest market share owing to its increasing prevalence worldwide
In terms of end use, the hospital segment held the largest share in 2023, owing to the increasing number of hospitals in developing countries and growing competition among healthcare service providers
The imaging center segment is expected to experience the fastest growth rate during the forecast period due to its convenience, proximity, and lower costs to patients and insurers
Asia Pacific is anticipated to be growing at the fastest CAGR during the forecast period due to the presence of untapped opportunities in the emerging economies in China and India
Grand View Research has segmented the global magnetoencephalography market based on application, end-use, and region:
Magnetoencephalography Application Outlook (Revenue, USD Million, 2018 - 2030)
Clinical
Dementia
Autism
Schizophrenia
Multiple Sclerosis
Stroke
Epilepsy
Others
Research
Magnetoencephalography End Use Channel Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Imaging Ccenters
Academic and Rresearch Iinstitutes
Magnetoencephalography Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Magnetoencephalography Market
Compumedics Limited
MEGIN
Ricoh
CTF MEG NEURO INNOVATIONS, INC.
FieldLine Inc.
Cerca Magnetics Limited
"The quality of research they have done for us has been excellent..."